Your browser doesn't support javascript.
loading
The efficacy of lorlatinib in a lung adenocarcinoma patient with a novel ALK G1202L mutation: a case report.
Meng, Zhaoting; Li, Ting; Wang, Pei; Lizaso, Analyn; Huang, Dingzhi.
Afiliação
  • Meng Z; Department of Thoracic Medical Oncology, Lung Cancer Diagnosis and Treatment Center, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer , Tianjin, China.
  • Li T; Department of Gastrointestinal Cancer Biology, Tianjin Medical University Cancer Institute and Hospital , Tianjin, China.
  • Wang P; Department of Thoracic Medical Oncology, Lung Cancer Diagnosis and Treatment Center, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer , Tianjin, China.
  • Lizaso A; Burning Rock Biotech , Guangzhou, China.
  • Huang D; Department of Thoracic Medical Oncology, Lung Cancer Diagnosis and Treatment Center, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer , Tianjin, China.
Cancer Biol Ther ; 22(1): 1-4, 2021 01 02.
Article em En | MEDLINE | ID: mdl-33380260

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Adenocarcinoma de Pulmão / Quinase do Linfoma Anaplásico / Aminopiridinas / Lactamas / Neoplasias Pulmonares Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Adenocarcinoma de Pulmão / Quinase do Linfoma Anaplásico / Aminopiridinas / Lactamas / Neoplasias Pulmonares Limite: Adult / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article